Publication:
SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/20.500.12105/18783
DOI: 10.1007/s12094-022-02814-x
Full text access: http://hdl.handle.net/10668/21108

Publication date

2022-03-18

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

Metrics
Google Scholar
Export
MarcXML METS

Research Projects

Organizational Units

Journal Issue

Abstract

Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.

Description

Keywords

Clinical Practice Guidelines Diagnosis Follow-up Nasopharyngeal cancer Treatment

MeSH Terms

Humans Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms

DeCS Terms

Bibliographic citation

Collections

IBIMA-Plataforma BIONAND - Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (Andalucía)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)

Publisher version

Related dataset

Related publication

Document type

research article